{
    "id": 32002,
    "fullName": "CCR4 Q330*",
    "impact": "nonsense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "CCR4 Q330* results in a premature truncation of the Ccr4 protein at amino acid 330 of 360 (UniProt.org). Q330* results in impaired receptor internalization and elevated surface expression relative to wild-type Ccr4, and increased activation of Akt, cell proliferation, and cell migration in the presence of ligand in culture (PMID: 25488980).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 17516,
                    "pubMedId": 25488980,
                    "title": "Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25488980"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1233,
        "geneSymbol": "CCR4",
        "terms": [
            "CCR4",
            "CC-CKR-4",
            "CD194",
            "ChemR13",
            "CKR4",
            "CMKBR4",
            "HGCN:14099",
            "K5-5"
        ]
    },
    "variant": "Q330*",
    "createDate": "01/08/2020",
    "updateDate": "01/14/2020",
    "referenceTranscriptCoordinates": {
        "id": 186371,
        "transcript": "NM_005508",
        "gDna": "chr3:g.32954410C>T",
        "cDna": "c.988C>T",
        "protein": "p.Q330*",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 19704,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Buparlisib (BKM120) treatment inhibited activation of Akt, however, did not inhibit migration of an adult T cell leukemia/lymphoma cell line harboring CCR4 Q330* allele in culture (PMID: 25488980).",
            "molecularProfile": {
                "id": 34459,
                "profileName": "CCR4 Q330*"
            },
            "therapy": {
                "id": 680,
                "therapyName": "Buparlisib",
                "synonyms": null
            },
            "indication": {
                "id": 50523,
                "name": "adult T-cell leukemia",
                "source": "DOID"
            },
            "responseType": "conflicting",
            "references": [
                {
                    "id": 17516,
                    "pubMedId": 25488980,
                    "title": "Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25488980"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 34459,
            "profileName": "CCR4 Q330*",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 186371,
            "transcript": "NM_005508",
            "gDna": "chr3:g.32954410C>T",
            "cDna": "c.988C>T",
            "protein": "p.Q330*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "hg38"
        }
    ]
}